BBV154
BBV154 is a COVID-19 vaccine developed in India. It is an inactivated virus vaccine. The vaccine aims to provide immunity against the SARS-CoV-2 virus. It has undergone rigorous clinical trials. The Indian government has approved its use. BBV154 contributes to the country's vaccination efforts. It plays a crucial role in public health. The vaccine is part of India's broader strategy to combat the pandemic.
Bharat Biotech's intranasal COVID-19 vaccine, also known as iNCOVACC or BBV154, has been approved for use in India...
December 25, 2022